Search

Your search keyword '"Rudy P. Lackner"' showing total 5 results
Start Over Author "Rudy P. Lackner" Publication Year Range Last 3 years
5 results on '"Rudy P. Lackner"'

1. NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023

Author

David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Debora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Malcolm DeCamp, Thomas J. Dilling, Jonathan Dowell, Gregory A. Durm, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Sandip P. Patel, Tejas Patil, Patricio M. Polanco, Gregory J. Riely, Jonathan Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, and Miranda Hughes

Subjects
Oncology
Abstract

The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) provide recommendations for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus on neoadjuvant and adjuvant (also known as perioperative) systemic therapy options for eligible patients with resectable NSCLC.

Published
2023
Full Text
View/download PDF

2. NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022

Author

Douglas E. Wood, Ella A. Kazerooni, Denise Aberle, Abigail Berman, Lisa M. Brown, Georgie A. Eapen, David S. Ettinger, J. Scott Ferguson, Lifang Hou, Dipen Kadaria, Donald Klippenstein, Rohit Kumar, Rudy P. Lackner, Lorriana E. Leard, Inga T. Lennes, Ann N.C. Leung, Peter Mazzone, Robert E. Merritt, David E. Midthun, Mark Onaitis, Sudhakar Pipavath, Christie Pratt, Varun Puri, Dan Raz, Chakravarthy Reddy, Mary E. Reid, Kim L. Sandler, Jacob Sands, Matthew B. Schabath, Jamie L. Studts, Lynn Tanoue, Betty C. Tong, William D. Travis, Benjamin Wei, Kenneth Westover, Stephen C. Yang, Beth McCullough, and Miranda Hughes

Subjects
Oncology
Abstract

The NCCN Guidelines for Lung Cancer Screening recommend criteria for selecting individuals for screening and provide recommendations for evaluation and follow-up of lung nodules found during initial and subsequent screening. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Lung Cancer Screening.

Published
2022
Full Text
View/download PDF

4. NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022

Author

Douglas E, Wood, Ella A, Kazerooni, Denise, Aberle, Abigail, Berman, Lisa M, Brown, Georgie A, Eapen, David S, Ettinger, J Scott, Ferguson, Lifang, Hou, Dipen, Kadaria, Donald, Klippenstein, Rohit, Kumar, Rudy P, Lackner, Lorriana E, Leard, Inga T, Lennes, Ann N C, Leung, Peter, Mazzone, Robert E, Merritt, David E, Midthun, Mark, Onaitis, Sudhakar, Pipavath, Christie, Pratt, Varun, Puri, Dan, Raz, Chakravarthy, Reddy, Mary E, Reid, Kim L, Sandler, Jacob, Sands, Matthew B, Schabath, Jamie L, Studts, Lynn, Tanoue, Betty C, Tong, William D, Travis, Benjamin, Wei, Kenneth, Westover, Stephen C, Yang, Beth, McCullough, and Miranda, Hughes

Subjects
Lung Neoplasms, Humans, Mass Screening, Early Detection of Cancer
Abstract

The NCCN Guidelines for Lung Cancer Screening recommend criteria for selecting individuals for screening and provide recommendations for evaluation and follow-up of lung nodules found during initial and subsequent screening. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Lung Cancer Screening.

Published
2022

5. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

Author

David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Debora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Malcolm DeCamp, Thomas J. Dilling, Jonathan Dowell, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Jose M. Pacheco, Sandip P. Patel, Gregory J. Riely, Jonathan Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina Gregory, and Miranda Hughes

Subjects
Lung Neoplasms, Oncology, Carcinoma, Non-Small-Cell Lung, Humans, Immunotherapy, Neoplasm Recurrence, Local, Medical Oncology
Abstract

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. Patients with metastatic lung cancer who are eligible for targeted therapies or immunotherapies are now surviving longer. This selection from the NCCN Guidelines for NSCLC focuses on targeted therapies for patients with metastatic NSCLC and actionable mutations.

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results